{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T08:33:34Z","timestamp":1784709214014,"version":"3.55.0"},"reference-count":44,"publisher":"Society of Nuclear Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.2967\/jnumed.118.210294","type":"journal-article","created":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T20:35:18Z","timestamp":1526675718000},"page":"26-33","source":"Crossref","is-referenced-by-count":69,"title":["Development of <sup>64<\/sup>Cu-NOTA-Trastuzumab for HER2 Targeting: A Radiopharmaceutical with Improved Pharmacokinetics for Human Studies"],"prefix":"10.2967","volume":"60","author":[{"given":"Sang-Keun","family":"Woo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Jin","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Jung","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Hui","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byoung Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Sup","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwang Il","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Ho","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngho","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang Il","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Hyun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2018,5,18]]},"reference":[{"key":"2021051712125064000_60.1.26.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2010.05.003"},{"key":"2021051712125064000_60.1.26.2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1957"},{"key":"2021051712125064000_60.1.26.3","doi-asserted-by":"publisher","DOI":"10.1126\/science.3798106"},{"key":"2021051712125064000_60.1.26.4","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/S0140-6736(16)32417-5","article-title":"HER2-positive breast cancer","volume":"389","author":"Loibl","year":"2017","journal-title":"Lancet."},{"key":"2021051712125064000_60.1.26.5","doi-asserted-by":"publisher","DOI":"10.1177\/1758834015599389"},{"key":"2021051712125064000_60.1.26.6","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.157941"},{"key":"2021051712125064000_60.1.26.7","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-009-1158-1"},{"key":"2021051712125064000_60.1.26.8","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.108.057919"},{"key":"2021051712125064000_60.1.26.9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.8448"},{"key":"2021051712125064000_60.1.26.10","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.108.060392"},{"key":"2021051712125064000_60.1.26.11","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-015-0082-6"},{"key":"2021051712125064000_60.1.26.12","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.112.118612"},{"key":"2021051712125064000_60.1.26.13","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.113.122630"},{"key":"2021051712125064000_60.1.26.14","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.193888"},{"key":"2021051712125064000_60.1.26.15","first-page":"1338","article-title":"64Cu-DOTA-trastuzumab imaging in a HER2-positive intracranial patient-derived xenograft (PDX) model of breast cancer metastasis [abstract]","volume":"57","author":"Kristensen","year":"2016","journal-title":"J Nucl Med."},{"key":"2021051712125064000_60.1.26.16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.critrevonc.2016.07.008","article-title":"Zevalin\u00ae (ibritumomab tiuxetan): after more than a decade of treatment experience, what have we learned?","volume":"105","author":"Rizzieri","year":"2016","journal-title":"Crit Rev Oncol Hematol."},{"key":"2021051712125064000_60.1.26.17","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.114.141127"},{"key":"2021051712125064000_60.1.26.18","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.3390\/ijms16023932","article-title":"Tumor immunotargeting using innovative radionuclides","volume":"16","author":"Kraeber-Bod\u00e9r\u00e9","year":"2015","journal-title":"Int J Mol Sci."},{"key":"2021051712125064000_60.1.26.19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0705347104"},{"key":"2021051712125064000_60.1.26.20","first-page":"1113","article-title":"MIRD pamphlet no. 19: absorbed fractions and radionuclide S values for six age-dependent multiregion models of the kidney","volume":"44","author":"Bouchet","year":"2003","journal-title":"J Nucl Med."},{"key":"2021051712125064000_60.1.26.21","doi-asserted-by":"crossref","first-page":"86","DOI":"10.14316\/pmp.2016.27.2.86","article-title":"Image-based absorbed dosimetry of radioisotope","volume":"27","author":"Park","year":"2016","journal-title":"Prog Med Phys."},{"key":"2021051712125064000_60.1.26.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.apradiso.2009.02.060"},{"key":"2021051712125064000_60.1.26.23","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(84)90435-6"},{"key":"2021051712125064000_60.1.26.24","unstructured":"Snyder W Ford MR Warner G . MIRD Pamphlet No. 11: \u201cS,\u201d Absorbed Dose per Unit Cumulated Activity for Selected Radionuclides and Organs. Reston, VA: Society of Nuclear Medicine and Molecular Imaging; 1975:5\u2013257."},{"key":"2021051712125064000_60.1.26.25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2010.01480.x"},{"key":"2021051712125064000_60.1.26.26","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1200\/JCO.1998.16.2.462","article-title":"Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers","volume":"16","author":"Sj\u00f6gren","year":"1998","journal-title":"J Clin Oncol."},{"key":"2021051712125064000_60.1.26.27","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.07.032"},{"key":"2021051712125064000_60.1.26.28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052306"},{"key":"2021051712125064000_60.1.26.29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052122"},{"key":"2021051712125064000_60.1.26.30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200103153441101"},{"key":"2021051712125064000_60.1.26.31","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.06.557"},{"key":"2021051712125064000_60.1.26.32","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1097\/RLU.0000000000001820","article-title":"89Zr-trastuzumab PET\/CT for detection of human epidermal growth factor receptor 2\u2013positive metastases in patients with human epidermal growth factor receptor 2\u2013negative primary breast cancer","volume":"42","author":"Ulaner","year":"2017","journal-title":"Clin Nucl Med."},{"key":"2021051712125064000_60.1.26.33","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.8197"},{"key":"2021051712125064000_60.1.26.34","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.9366"},{"key":"2021051712125064000_60.1.26.35","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.167155"},{"key":"2021051712125064000_60.1.26.36","doi-asserted-by":"publisher","DOI":"10.2174\/138161207779313768"},{"key":"2021051712125064000_60.1.26.37","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-85-20780"},{"key":"2021051712125064000_60.1.26.38","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1152\/ajplegacy.1966.210.5.1059","article-title":"Metabolism of 64Cu-labeled copper by the isolated rat liver","volume":"210","author":"Owen","year":"1966","journal-title":"Am J Physiol."},{"key":"2021051712125064000_60.1.26.39","doi-asserted-by":"publisher","DOI":"10.1021\/ic00142a037"},{"key":"2021051712125064000_60.1.26.40","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1021\/ic00253a038","article-title":"Thermodynamic study of lanthanide complexes of 1,4,7-triazacyclononane-N,N\u2032,N\u2033-triacetic acid and 1,4,7,10-tetraazacyclododecane-N,N\u2032,N\u2033,N\u2032\u2032\u2032-tetraacetic acid","volume":"26","author":"Cacheris","year":"1987","journal-title":"Inorg Chem."},{"key":"2021051712125064000_60.1.26.41","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1021\/ic960605p","article-title":"The nonexistent crystals of macrocyclic nickel (III): structure of the cobalt (III) complex of 1, 4, 7-triazacyclononane-N,N\u2032,N\u2033-triacetate","volume":"36","author":"Boeyens","year":"1997","journal-title":"Inorg Chem."},{"key":"2021051712125064000_60.1.26.42","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.1021\/mp500283k","article-title":"PET and SPECT imaging of a radiolabeled minigastrin analogue conjugated with DOTA, NOTA, and NODAGA and labeled with 64Cu, 68Ga, and 111In","volume":"11","author":"Roosenburg","year":"2014","journal-title":"Mol Pharm."},{"key":"2021051712125064000_60.1.26.43","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1089\/cbr.2017.2337","article-title":"Comparative evaluation of using NOTA and DOTA derivatives as bifunctional chelating agents in the preparation of 68Ga-labeled porphyrin: impact on pharmacokinetics and tumor uptake in a mouse model","volume":"33","author":"Guleria","year":"2018","journal-title":"Cancer Biother Radiopharm."},{"key":"2021051712125064000_60.1.26.44","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s11307-014-0783-7","article-title":"Patient-specific dosimetry using pretherapy [124I]m-iodobenzylguanidine ([124I]mIBG) dynamic PET\/CT imaging before [131I]mIBG targeted radionuclide therapy for neuroblastoma","volume":"17","author":"Huang","year":"2015","journal-title":"Mol Imaging Biol."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.118.210294","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T20:33:50Z","timestamp":1621283630000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.118.210294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,18]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1,2]]},"published-print":{"date-parts":[[2019,1]]}},"alternative-id":["10.2967\/jnumed.118.210294"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.118.210294","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,18]]}}}